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The notion that cellular membranes contain distinct microdomains, acting as scaffolds for
signal transduction processes, has gained considerable momentum. In particular, a class of
such domains that is rich in sphingolipids and cholesterol, termed as lipid rafts, is thought
to compartmentalize the plasma membrane, and to have important roles in survival and
cell death signaling in mammalian cells. Likewise, yeast lipid rafts are membrane domains
enriched in sphingolipids and ergosterol, the yeast counterpart of mammalian cholesterol.
Sterol-rich membrane domains have been identiﬁed in several fungal species, including the
budding yeast Saccharomyces cerevisiae, the ﬁssion yeast Schizosaccharomyces pombe
as well as the pathogens Candida albicans and Cryptococcus neoformans.Yeast rafts have
been mainly involved in membrane trafﬁcking, but increasing evidence implicates rafts in
a wide range of additional cellular processes. Yeast lipid rafts house biologically important
proteins involved in the proper function of yeast, such as proteins that control Na+, K+,
and pH homeostasis, which inﬂuence many cellular processes, including cell growth and
death. Membrane raft constituents affect drug susceptibility, and drugs interacting with
sterols alter raft composition and membrane integrity, leading to yeast cell death. Because
of the genetic tractability of yeast, analysis of yeast rafts could be an excellent model to
approach unanswered questions of mammalian raft biology, and to understand the role
of lipid rafts in the regulation of cell death and survival in human cells. A better insight
in raft biology might lead to envisage new raft-mediated approaches to the treatment of
human diseases where regulation of cell death and survival is critical, such as cancer and
neurodegenerative diseases.
Keywords: lipid rafts, membrane domains, ergosterol, yeast, S. cerevisiae, ion homeostasis, nutrient transporters,
cell death
INTRODUCTION
Apoptosis is an intrinsic cell death process that plays critical roles
in the normal development and health of multicellular organ-
isms. However, in the last years, growing evidence suggests that
apoptosis-like cell death also occurs in a number of unicellu-
lar organisms, including yeast (Madeo et al., 2002, 2004; Wissing
et al., 2004; Pereira et al., 2008; Carmona-Gutierrez et al., 2010;
Sousa et al., 2011). Some features of apoptotic-like cell death
can be induced in yeast following stress conditions, such as
acetic acid (Ludovico et al., 2001, 2002), membrane-permeable
C2-ceramide (Carmona-Gutierrez et al., 2011), hydrogen perox-
ide (H2O2; Madeo et al., 1999; Ribeiro et al., 2006), hyperosmotic
(Silva et al., 2005; Ribeiro et al., 2006), and NaCl (Huh et al., 2002;
Wadskog et al., 2004) stress.
Cell membranes are structurally heterogeneous, composed of
discrete domains with unique physical and biological properties.
The concept of the organization of membrane lipid compo-
nents into domains (Karnovsky et al., 1982), and the subsequent
demonstration of the existence in the plasma membrane of a par-
ticular type of microdomain enriched in sterols and sphingolipids,
named as lipid rafts (Simons and Ikonen, 1997; Brown and Lon-
don, 2000; Simons and Toomre, 2000; Ikonen, 2001; Maxﬁeld,
2002), have profoundly changed our view of membrane organiza-
tion and membrane-regulated processes. Membrane domains can
form through a number of mechanisms involving lipid–lipid and
protein–lipid interactions.
Despite lipid rafts have different sizes depending on the mem-
brane composition, a consensus deﬁnition of a lipid raft developed
at the 2006 Keystone Symposium of Lipid Rafts and Cell Function,
held in Steamboat Springs (CO, USA), concluded that “mem-
brane rafts are small (10–200 nm), heterogenous, highly dynamic,
sterol- and sphingolipid-enriched domains that compartmental-
ize cellular processes. Small rafts can sometimes be stabilized to
form larger platforms through protein–protein and protein–lipid
interactions” (Pike, 2006). In resting cells, rafts appear small and
unstable, and the current consensus is that their sizes are smaller
than the optical diffraction limit (250 nm). Following stimulation,
raft-preferring proteins are clustered, inducing larger and stabi-
lized rafts, likely through lipid lateral diffusion and coalescence of
small raft units.
A critical issue in the studies of raft biology lies in the dif-
ﬁculty to visualize rafts in living cells, unless they coalesce in
large raft platforms. Thus, most of the evidence for their iden-
tiﬁcation relies on indirect methods, such as the use of non-ionic
detergent extraction. On these grounds, rafts are usually deﬁned
as the insoluble fraction or detergent-resistant membrane (a.k.a.,
DRM) after non-ionic detergent solubilization at 4◦C, which can
be isolated by ﬂotation in density gradients. The association
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of a protein with cholesterol-rich rafts is strengthened when it
becomes detergent-soluble after depletion of cholesterol from the
membrane by the use of methyl-β-cyclodextrin or other agents.
Nevertheless, the physiological existence of rafts has been chal-
lenged by a number of criticisms (Munro, 2003; Lichtenberg
et al., 2005; Lingwood and Simons, 2007; Simons and Gerl, 2010),
in particular regarding the use of detergents that could lead to
artifacts and misinterpretations since, for instance, Triton has
been shown to promote the formation of ordered domains in
model bilayers (Heerklotz, 2002). Also, a main concern has been
raised on the diverse effects that might be expected by depleting
cholesterol from the membrane because cholesterol has important
functions in the whole plasma membrane, apart from form-
ing lipid rafts. On these grounds, the functional involvement of
rafts as well as the raft localization of proteins based only on
the use of detergents and cholesterol depletion has been chal-
lenged, and therefore caution should be taken before assigning a
role of rafts in different biological processes. In addition, the evi-
dence for the presence of rafts in the plasma membrane of living
cells has, until recently, not been compelling, thus raising some
doubts about the physiological existence of rafts. However, the
advent of new microscopy techniques has ﬁnally demonstrated
the existence of rafts in the cell. The use of stimulated emission
depletion (STED) microscopy has proved that sphingolipids and
glycosylphosphatidylinositol (GPI)-anchored proteins are tran-
siently trapped in cholesterol-dependent molecular complexes
in live cells (Eggeling et al., 2009). In this regard, the applica-
tion of novel technologies, such as ﬂuorescence resonance energy
transfer (FRET), ﬂuorescence polarization anisotropy (FPA), total
internal reﬂection ﬂuorescence (TIRF) microscopy, single quan-
tum dot tracking, single particle tracking (SPT), and ﬂuorescence
correlation spectroscopy (FCS), have provided evidence for the
localization of GPI-anchored proteins and other lipid-modiﬁed
proteins in cholesterol-dependent clusters (Kusumi et al., 2004;
Sharma et al., 2004; Lenne et al., 2006; Marguet et al., 2006; Vyas
et al., 2008; Pinaud et al., 2009). In addition, near-ﬁeld scan-
ning optical microscopy (NSOM) in combination with quantum
dots showed that T cell stimulation triggers the organization
of T cell receptors in nanodomains in live cells (Zhong et al.,
2009; van Zanten et al., 2010). The development of the above
high temporal and spatial resolution techniques has allowed to
locate different molecular constituents in membrane domains
with reduced mobility. The combined use of different biophysical,
biochemical, and genetic technologies are now providing evidence
demonstrating the existence of sterol-dependent membrane raft
domains as well as their role in critical physiological functions.
Despite some technical and conceptual limitations, as stated above,
resistance to non-ionic detergent solubilization, together with
ﬂotation in gradient density centrifugation and manipulation of
sterol, remain as the most widely used techniques for studying
lipid rafts.
There are a wide number of reports showing that rafts in
mammalian cells house proteins involved in cell survival and
growth, as well as in the proper functioning of immune system
receptors (Simons and Toomre, 2000; Szoor et al., 2010). In this
regard, cancer cells, usually showing an increased ability to pro-
liferate and survive, have been found to have higher levels of
cholesterol (Dessi et al., 1994; Kolanjiappan et al., 2003; Freeman
and Solomon, 2004; Tosi and Tugnoli, 2005) and cholesterol-rich
lipid rafts (Li et al., 2006) than their normal counterparts. Nev-
ertheless, in the last decade, a number of death receptors and
downstream apoptotic signaling molecules have also been local-
ized in cholesterol- and sphingolipid-rich lipid rafts in cancer
cells (Gajate and Mollinedo, 2001, 2005, 2007; Gajate et al., 2004;
Mollinedo and Gajate, 2006; Reis-Sobreiro et al., 2009; Mollinedo
et al., 2010a). The localization of the death-inducing signaling
complex (DISC), a major apoptotic complex containing Fas/CD95
death receptor, Fas-associated death domain-containing protein
(FADD) and procaspase-8, in lipid rafts has been shown by elec-
tron microscopy in T cell leukemic cells, when they are engaged
to undergo apoptosis (Gajate et al., 2009a). In addition, raft nan-
odomains have been shown, following a FCS strategy, to be present
in both the outer and inner leaﬂets of the plasmamembrane and to
play a crucial role in triggering the survival phosphatidylinositol-3
kinase/Akt signaling pathway, by facilitating Akt recruitment and
activationuponphosphatidylinositol-3,4,5-triphosphate accumu-
lation in the plasma membrane (Lasserre et al., 2008). On these
grounds, mammalian cell lipid rafts behave as platforms that can
house different, and even opposite signaling processes, such as sur-
vival and apoptosis, and therefore these membrane domains play
a critical role in the modulation of cell signaling that regulates
cell fate.
Lipid rafts have also been identiﬁed in yeast as membrane
domains enriched in ergosterol and sphingolipids (Wachtler and
Balasubramanian, 2006). The budding yeast Saccharomyces cere-
visiae is one of the best characterized eukaryotic organisms. In
spite of its simplicity as a free-living unicellular fungus, yeast cells
are similar to higher eukaryotes regarding the cell structure and
several physiological processes. Due to its genetic tractability and
increasing wealth of accessible data, yeast has become a model
system of choice for the study of different physiological processes
occurring in mammalian cells. In this regard, yeast could be an
interesting biological system to analyze the role of lipid rafts in
both survival and cell death responses, despite yeast lack death
receptors and most of the typical apoptotic signaling molecules
present in mammalian cells.
RAFTS IN YEASTS
Regarding the lipid constituents of lipid rafts, and although
the lipid levels vary between different cell types, the plasma
membrane of the mammalian cell usually contains, on a molar
basis, about 30–40% cholesterol and 10–20% sphingomyelin
of plasma membrane lipids, while glycosphingolipids are usu-
ally present at low levels (Lange et al., 1989; van Meer, 1989).
However, yeasts do not have sphingomyelin, but instead have
inositol phosphosphingolipids, which may function as orthologs
of mammalian sphingomyelin (Matmati and Hannun, 2008).
In addition, unlike mammalian cells that have cholesterol,
yeast contain ergosterol, serving the same function as choles-
terol in animal cells. Ergosterol is even a better raft former
than cholesterol (Xu et al., 2001). Studies on the generation
of model membranes from yeast total lipid extracts led to the
conclusion that formation of membrane domains depended on
speciﬁc interactions between yeast sphingolipids and ergosterol
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(Klose et al., 2010). This selective interaction between yeast
sphingolipids and ergosterol results in phase separation into
membrane domains with liquid ordered- and liquid disordered-
like properties, that is in raft formation (Klose et al., 2010).
Thus, whereas lipid rafts in mammalian cells contain choles-
terol and sphingomyelin or glycosphingolipids (Simons and Iko-
nen, 1997), raft domains in S. cerevisiae contain ergosterol and
complex sphingolipids (Kubler et al., 1996; Bagnat et al., 2000),
including inositol-phosphoceramide (IPC), mannose-inositol-
phosphoceramide (MIPC), and mannose-(inositol phosphate)2-
ceramide (M(IP)2C) (Dickson et al., 2006).
Lipid rafts are enriched in sterols, composed of a four-ring
structure with an aliphatic tail that can pack tightly with the
lipid acyl chains of sphingolipids to create a compacted region of
condensed bilayer termed the liquid-ordered state (Munro, 2003;
Megha et al., 2006). Because of its rather unique lipid composition,
lipid rafts are more resistant to extraction with cold non-ionic
detergents, and therefore they were originally deﬁned as DRMs,
due to their relative insolubility in cold non-ionic detergents (Lon-
don and Brown, 2000; Maxﬁeld, 2002; Simons and Gerl, 2010). In
the yeast, rafts have also been deﬁned biochemically as DRMs and
proven to be critical for protein sorting through the endoplasmic
reticulum and Golgi apparatus (Bagnat et al., 2000, 2001; Bagnat
and Simons, 2002). The terms lipid raft, liquid-ordered domain,
and DRM are widely used indistinctly and are suggested to refer
to the same chemico-biological entity. However, in a very strict
way, they might have different implications and caution should be
taken (Lichtenberg et al., 2005).
The yeast sphingolipid is peculiar in that it contains a satu-
rated very long-chain fatty acid with 26 carbon atoms (Schneiter
et al., 1999, 2004), which is synthesized and coupled to raft-located
proteins, like the proton pumping ATPase Pma1p, already in the
endoplasmic reticulum. Then, the resulting protein–lipid complex
is transported and sorted as an entity to the plasma membrane.
This rather long C26 fatty acid is required for proper assembly
of the protein–lipid complex and transport to the membrane, as
a shortening to C22 fatty acid by mutations impairs raft associa-
tion of Pma1p, and induces Pma1p degradation by rerouting the
ATPase enzyme from the plasma membrane to the vacuole (Gaigg
et al., 2006; Toulmay and Schneiter, 2007).
Another important difference between mammalian cells and
yeast cells lies in that lipid raft formation occurs primarily in the
Golgi apparatus in mammals (Brown and Rose, 1992), whereas it
takes place in the endoplasmic reticulum in yeast, where is sug-
gested that proteins associate with yeast rafts (Bagnat et al., 2000).
In both yeast and mammalian cells, sphingolipids and sterols are
mainly present in the plasmamembrane (Lange et al., 1989; Patton
and Lester, 1991; Zinser and Daum, 1995), but these molecules
are synthesized in compartments of the early secretory pathway
(Daum et al., 1998; Futerman and Riezman, 2005), and there-
fore raft-located proteins could be recruited into these domains in
other subcellular structures distinct from the plasma membrane.
Thus, in yeast newly synthesized Gas1p, a GPI-anchored protein,
and Pma1p have been found to be recruited to lipid rafts in the
endoplasmic reticulum (Bagnat et al., 2000; Lee et al., 2002).
Because a major constituent of lipid rafts is sterol, the naturally
ﬂuorescent sterol-binding antibiotic ﬁlipin has been widely used
to detect regions with high sterol content in the plasma membrane
of fungi. The use of this compound has led to the identiﬁcation
of large sterol-rich domains (SRDs) in the plasma membranes of
fungi (Wachtler et al., 2003; Alvarez et al., 2007), ranging from
about 3 to 15 μm2. Due to the dynamic nature of lipid rafts and
to their ability to aggregate, clusters of rafts in mammalian cells
can be formed under different stimuli to lead to raft platforms as
big as the ones reported for some fungi (Ausili et al., 2008). In this
regard, it might be envisaged that SRDs in yeasts correspond to
clusters of sterol-rich rafts or raft platforms, which are required
for the accomplishment of speciﬁc functions. This clustering of
rafts may be critical for the proper onset of certain cell functions,
which might require the concentration of a great amount of pro-
teins in speciﬁc sites of the cell, thus leading to cell movement,
cytokinesis, etc. On these grounds, lipid rafts act as dynamic and
mobile platforms that transport the required proteins at the proper
place to act.
Sterol-rich membrane domains have been identiﬁed in several
fungal species, including the budding yeast S. cerevisiae (Kubler
et al., 1996; Bagnat et al., 2001), the ﬁssion yeast Schizosaccha-
romyces pombe (Wachtler et al., 2003), as well as the pathogen
yeasts Candida albicans (Martin and Konopka, 2004; Alvarez et al.,
2007) and Cryptococcus neoformans (Siafakas et al., 2006; Alvarez
et al., 2007), having being involved in a number of important pro-
cesses like mating (Nichols et al., 2004; Proszynski et al., 2006),
cytokinesis (Rajagopalan et al., 2003; Wachtler et al., 2003), and
hyphal formation (Martin and Konopka, 2004).
Sterol-rich domains are polarized in the rod-shaped S. pombe
throughout the vegetative life cycle in a cell cycle-dependent way,
namely they are located to the growing cell ends during inter-
phase, and to the medial zone where cells undergo cytokinesis,
as well as at the tips of mating projections (Rajagopalan et al.,
2003; Wachtler et al., 2003; Wachtler and Balasubramanian, 2006;
Alvarez et al., 2007). Thus, in ﬁssion yeast, rafts localize to regions
of polarized growth and to the division site. Unlike to what hap-
pens in S. pombe, sterols are distributed uniformly throughout
the plasma membrane in the vegetative life cycle of the bud-
ding yeast S. cerevisiae. However, ﬁlipin-stained rafts are also
detected at the tips of cells induced with mating pheromone
(Bagnat and Simons, 2002; Proszynski et al., 2006; Alvarez et al.,
2007). In the human pathogens C. neoformans and C. albicans,
sterols are concentrated at the leading edges of mating projec-
tions, at the actively growing sites at bud tips, at sites of septation,
and at the tip of hyphal growth (Martin and Konopka, 2004;
Alvarez et al., 2007).
RAFTS IN YEAST PATHOGENS
Proteomic analysis in DRMs from C. albicans led to the identiﬁca-
tion of 29 proteins, including the well-known lipid raft marker in
S. cerevisiae Pma1p (Insenser et al., 2006). Surprisingly, only three
proteins (∼10%) were typically located in the plasma membrane,
whereas most of raft-located proteins were usually present in
internal membranes, including proteins located in mitochondrial
(31%), Golgi (7%), and endoplasmic reticulum (7%) membranes.
This could support the existence of raft domains in themembranes
of mitochondria, endoplasmic reticulum, and Golgi, as reported
by different researchers (Bini et al., 2003; Mielenz et al., 2005;
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Mollinedo et al., 2011). The proteins located in C. albicans rafts
were involved in a number of biological processes, including lipid
metabolism, cell wall biogenesis, protein metabolism, electron
transport, and ATP synthesis (Insenser et al., 2006). In addition
heat shock proteins were also present (Insenser et al., 2006), simi-
larly to what has been observed in mammalian cells (Nieto-Miguel
et al., 2008). Likewise, ATP synthase was also located at the raft
membranes in C. albicans (Insenser et al., 2006), and a simi-
lar raft location for this enzyme has been found in proteomic
studies conducted in mammalian cells (Bae et al., 2004), leading
to the suggestion that this protein might be located in plasma
membrane rafts as well as in mitochondria (Bae et al., 2004). Fur-
thermore, it is worth mentioning the presence in C. albicans lipid
rafts of a series of proteins involved in lipid metabolism and mul-
tidrug efﬂux, such as: Erg11p and Scs7p, involved in the lipid
metabolism of major raft components (ergosterol and ceramide;
Insenser et al., 2006); Rta2p, a translocase that moves sphingolipid
long chain bases from the inside to the outside membrane (Wang
et al., 2012); and theATP-binding cassette (ABC) multidrug trans-
porter CaCdr1p (Pasrija et al., 2008). The presence of cytosolic
proteins in the C. albicans rafts suggest that protein–protein inter-
actions could play a major role in bringing soluble proteins to the
raft domains.
Candida albicans-associated bloodstream infections are linked
to the ability of this yeast to form bioﬁlms (Mukherjee et al.,
2005). These latter are aggregates of microbial cells, adhering to
each other, which are embedded within a self-produced matrix of
extracellular polymeric substances, usually made up of extracellu-
lar DNA, proteins, and polysaccharides, and represent a common
mode of microbial growth. Microbes growing as bioﬁlm are highly
resistant to commonly used antimicrobial drugs. Candida bioﬁlms
associated with indwelling devices provide a protected niche for
the fungal cells, where they can evade the host immune system,
and are especially problematic due to their inherent resistance
to commonly used antifungal agents (Chandra et al., 2007). The
microbial cells growing in a bioﬁlm are physiologically distinct
from planktonic cells of the same organism, which are single-
cells ﬂoating in a liquid medium. Bioﬁlm formation by Candida
species is believed to contribute to invasiveness of these fungal
species, and there is a correlation between C. albicans bioﬁlms
and fungal pathogenesis. By using lipidomics, a signiﬁcant differ-
ence was observed in the lipid proﬁles of C. albicans bioﬁlms and
planktonic cells. Bioﬁlms contained higher levels of phospholipid
and sphingolipids than planktonic cells. In the early phase, levels
of lipid in most classes were signiﬁcantly higher in bioﬁlms com-
pared to planktonic cells. The unsaturation index of phospholipids
decreased with time, with this effect being particularly strong for
bioﬁlms. Inhibition of the biosynthetic pathway for sphingolipid
(M(IP)2C) by myriocin or aureobasidin A, and disruption of the
gene encoding inositolphosphotransferase 1 (IPT1), abrogated the
ability of C. albicans to form bioﬁlms, suggesting that lipid rafts
might be involved in bioﬁlm formation (Lattif et al., 2011). The
differences in lipid proﬁles between bioﬁlms and planktonic Can-
dida cells may have important implications for the biology and
antifungal resistance of bioﬁlms (Lattif et al., 2011).
In addition, lipid rafts have been found to be important plat-
forms for the concentration of certain virulence factors at the cell
surface of pathogenic fungi, to allowefﬁcient access to enzyme sub-
strate and/or to provide rapid release to the external environment.
Thus, rafts from the fungal pathogen C. neoformans contain the
virulence determinant phospholipase B1 (Plb1p), a GPI-anchored
protein, and the antioxidant virulence factor Cu/Zn superoxide
dismutase (Sod1p; Siafakas et al., 2006). The enzyme Plb1p con-
tains phospholipase B (PLB), lysophospholipase (LPL), and LPL
transacylase (LPTA) activities (Chen et al., 1997a,b), and therefore
it might affect raft lipid composition.
LIPID RAFTS AND ION HOMEOSTASIS IN YEAST
The maintenance of ion homeostasis in response to changes in
the environment is vital to all living cells. In yeast cells, the active
transport of inorganic ions and nutrients relies on the existence
of an electrochemical gradient of protons across the plasma mem-
brane. In S. cerevisiae, this electrochemical gradient is mainly
generated by the essential H+-ATPase gene, PMA1, which encodes
one of the most abundant proteins in the yeast plasma membrane
(Serrano et al., 1986). This Pma1p-mediated electrochemical gra-
dient is balanced by the activity of a number of symporters and
antiporters, but the high-afﬁnity potassium uptake through the
plasmamembrane transporters Trk1p andTrk2p, the former being
the most biologically relevant potassium transporter, is the major
consumer of the gradient (Gaber et al., 1988; Ko and Gaber, 1991;
Madrid et al., 1998). Potassium transport into yeast cells results in
plasma membrane depolarization, leading to Pma1p stimulation
and a concomitant cytosolic alkalinization (Rodriguez-Navarro,
2000). Thus, the regulation of both Pma1p and Trk1p is criti-
cal for the modulation of the electrical membrane potential and
intracellular pH. Thus, Pma1p and the high-afﬁnity potassium
transporters Trk1p and Trk2p are the major determinants of
yeast membrane potential and internal pH, and thus should be
co-ordinately regulated. The plasma membrane proton ATPase
Pma1p is a resident raft protein (Bagnat et al., 2001). The major
K+ transporters, Trk1p and Trk2p, have also been reported to
be present in lipid rafts (Zeng et al., 2004; Yenush et al., 2005).
Intracellular pH plays a critical role in modulating the activity
of many cellular systems, including those regulating cell death,
both in yeasts (Ludovico et al., 2001, 2002; Sokolov et al., 2006)
and mammalian cells (Perez-Sala et al., 1995; Gottlieb et al., 1996;
Meisenholder et al., 1996).
In S. cerevisiae, intracellular pH and K+ concentrations affect
many cellular activities, including cell growth and death, and
thereby they must be tightly controlled through the regulation of
the H+-pumping ATPase Pma1p and the major K+ transporters
Trk1p and Trk2p (Yenush et al., 2002, 2005). Pma1p is an electro-
genic pump with an optimal pH of 6.5 and therefore is well suited
to set the intracellular pH at a neutral value (Portillo, 2000), and
together with Trk1p, both systems are the major regulators of cell
volume, turgor, membrane potential, and pH in yeast. Potassium
accumulation through Trk1p can be harmful to the cell, lead-
ing to an increase in turgor pressure and the risk of cell lysis.
Trk1p is activated by Hal4p and Hal5p kinases and inhibited by
the Ppz1p and Ppz2p phosphatases. Hal3p is a negative regulatory
subunit of the Ppz1p Ser/Thr phosphatase (de Nadal et al., 1998),
and it has been shown that the inhibition of Ppz1p by Hal3p is
pH dependent (Yenush et al., 2005). Interestingly, Ppz1p–Hal3p
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interaction would act as an intracellular pH sensor, and a model
has been proposed for the modulation of H+ and K+ homeosta-
sis through the regulation of Trk1p activity by intracellular pH
(Yenush et al., 2005). At a relatively alkaline pH the interaction
between Hal3p and Ppz1p would be destabilized, and hence the
Ppz1p phosphatase would act on Trk1p to decrease the potas-
sium uptake into the cell. Thus, following accumulation of K+,
cells use then a concomitant increase in intracellular pH through
the extrusion of protons by Pma1p to downregulate potassium
transport.
Ppz1p has been mostly located at the plasma membrane,
although some of this protein was also present in internal non-
vacuolar membranes, likely the endoplasmic reticulum and/or the
nuclear membrane (Yenush et al., 2005). However, unlike Trk1p,
Ppz1p was not found in DRMs (Yenush et al., 2005). Nevertheless,
because the raft-located Trk1p has been shown to interact with
Ppz1p (Yenush et al., 2005), it cannot be ruled out that lipid rafts
might transiently be a place where these proteins could interact
each other, as shown for other non-raft proteins in mammalian
cells that are translocated and recruited in lipid rafts to regulate cell
death signaling (Gajate et al., 2004; Gajate and Mollinedo, 2007;
Nieto-Miguel et al., 2008; Reis-Sobreiro et al., 2009).
The above data on yeast are of major importance for mam-
malian cells, as regulation of potassium transport and intracellular
pH homeostasis is implicated in many diseases (Shieh et al., 2000),
including cancer, and it is plausible to envisage that similar
transduction pathways connecting pH and potassium homeosta-
sis might play a critical role in human disease and constitute
interesting therapeutic opportunities.
In addition, the plasma membrane Na+/H+ antiporter Nha1p
from the budding yeast S. cerevisiae, which plays an important
role in intracellular Na+ as well as pH homeostasis, by mediating
the exchange of Na+ for H+ across the plasma membrane, has
also been shown to associate with lipid rafts (Mitsui et al., 2009).
In lcb1-100 mutant cells, which are temperature-sensitive for sph-
ingolipid synthesis, newly synthesized Nha1p failed to localize to
the plasma membrane at the non-permissive temperature, but
the addition of phytosphingosine or the inhibition of endocytosis
in lcb1-100 cells restored the targeting of Nha1p to the plasma
membrane (Mitsui et al., 2009).
Thus, Pma1p, Trk1p, and Nha1p, regulating membrane poten-
tial and intracellular pH, are located in lipid rafts in S. cerevisiae
(Figure 1), and they are critical in the modulation of ion home-
ostasis, by keeping the major monovalent cations (H+, K+, and
Na+), mainly through proteins that extrude H+ and Na+ and
import K+ ions (Figure 1), at the appropriate narrow range of
ion concentrations for the proper function of distinct biological
processes.
NUTRIENT TRANSPORTERS IN YEAST LIPID RAFTS
Table 1 shows a number of proteins that have been located in lipid
rafts in S. cerevisiae, including proteins involved in ion home-
ostasis, nutrient transport, mating, stress response, and actin
cytoskeleton organization.
Several nutrient transporters have been located in lipid rafts in
S. cerevisiae (Table 1). The arginine/H+ symporter Can1p (argi-
nine permease) has been found to be present in lipid rafts in
S. cerevisiae (Malinska et al., 2003). Double labeling experiments
with Can1p-GFP and Pma1p-RFP-containing yeast cells showed
that these proteins were located in two different non-overlapping
membrane domains (Malinska et al., 2003), suggesting the pres-
ence of distinct rafts in the same yeast cell. The general amino acid
permeaseGap1ppresent at theplasmamembrane is also associated
with DRMs, and in the absence of sphingolipid synthesis Gap1p
fails to accumulate at the plasma membrane and is missorted
to the vacuole (Lauwers and Andre, 2006). Likewise, the hexose
FIGURE 1 | Ion homeostasis in yeast.This scheme portrays the major proteins, Pma1p, Trk1p, Trk2p, and Nha1p, involved in maintaining ion homeostasis in
S. cerevisiae.
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transporter Hxt1p (low-afﬁnity glucose permease) present at the
cell surface was also associated with DRMs (Lauwers and Andre,
2006). The plasma membrane protein uracil/H+ symporter Fur4p
(uracil permease) has also been reported to be associated with
lipid rafts in S. cerevisiae (Hearn et al., 2003). The amount of
this protein in plasma membrane is highly regulated. Under stress
conditions, including heat stress and high concentrations of uracil
in the culturemedium,Fur4p is degradedby aprocess that includes
phosphorylation, ubiquitination, endocytosis, and transport to
the vacuolewhere theprotein is eventually hydrolyzed (Galan et al.,
1998; Marchal et al., 2002). Because rafts act as platforms for the
integration andmodulation of signaling pathways andprocesses, it
could be envisaged that the raft location of Fur4p might be critical
for its regulation.
The plasma membrane localization of the tryptophan perme-
ase Tat2p is regulated by the external tryptophan concentration
and is dependent on lipid rafts. In wild-type cells, Tat2p is
transported from the Golgi apparatus to the vacuole at high tryp-
tophan level, and to the plasma membrane at low tryptophan
level. However, Tat2p is missorted to the vacuole at low tryp-
tophan concentration in the erg6 deleted mutant (ERG6 gene
encodes S-adenosylmethionine 24 methyltransferase, acting in
the last steps of ergosterol biosynthesis by converting zymosterol
to fecosterol; Umebayashi and Nakano, 2003), and following yeast
treatmentwith the ergosterol biosynthesis inhibitor zaragozic acid,
that inhibits squalene synthetase, which catalyzes the ﬁrst commit-
ted step in the formation of cholesterol/ergosterol (Daicho et al.,
2007). Likewise, additional proteins, such as Fus1p, a plasma
membrane protein required for yeast mating, is excluded from
rafts and missorted to the vacuole in the erg6 mutant (Bagnat
and Simons, 2002). These evidences support the view that several
plasma membrane proteins can be missorted in erg6 mutants
due to impaired raft association, and this might underlie the mat-
ing deﬁciency (Gaber et al., 1989) and drug hypersensitivity (Kaur
and Bachhawat, 1999; Gupta et al., 2003; Maresova et al., 2009) of
erg6mutants.
Furthermore, as shown in Table 1, mating projection-
localized proteins Fus2p, Fig1p, Sho1p, Ste6p, and Prm1p have
been found to be associated with DRMs (Bagnat and Simons,
2002), supporting a critical role for lipid rafts in the mating
process.
RAFTS AND CELL DEATH IN YEAST
Dysregulation of ion homeostasis mediates cell death, and this
represents the mechanistic basis by which a growing number of
amphipathic but structurally unrelated compounds elicit antifun-
gal activity (Zhang et al., 2012). Pma1p is displaced from lipid
rafts and delivered and degraded to the vacuole upon S. cerevisiae
incubation with edelfosine (Zaremberg et al., 2005), an amphi-
pathic antitumor ether phospholipid that affects and reorganizes
lipid rafts (Gajate et al., 2004, 2009a; Ausili et al., 2008). Because
Pma1p is mainly involved in maintaining ion homeostasis and
membrane potential in yeast, its displacement from lipid rafts,
following treatment of S. cerevisiae with the ether phospholipid
edelfosine, has been shown to lead to yeast cell death (Zarem-
berg et al., 2005). Edelfosine has been reported to have afﬁnity
for cholesterol, and for cholesterol-rich membranes such as rafts
(Ausili et al., 2008; Busto et al., 2008), because of the comple-
mentarity of the molecular geometrics of sterols and edelfosine
(Busto et al., 2008). Edelfosine induces apoptotic cell death in a
wide number of human cancer cells (Mollinedo et al., 1997, 2004,
2010a,b; Gajate and Mollinedo, 2002, 2007; Gajate et al., 2012)
through raft reorganization and redistribution of the raft protein
content (Gajate and Mollinedo, 2001, 2007; Gajate et al., 2004,
2009a). In human hematopoietic cancer cells, edelfosine treat-
ment leads to the recruitment of apoptotic molecules into raft
platforms, thus leading to the emerging concept of an apoptotic
“liquid-ordered”plasma membrane platform named as “cluster of
apoptotic signaling molecule-enriched rafts” (CASMERs; Gajate
and Mollinedo, 2005; Gajate et al., 2009b; Mollinedo and Gajate,
2010a,b). TheseCASMERsmay reduce the apoptotic signal thresh-
old by facilitating and stabilizing protein–protein interactions and
cross-talk between signaling pathways, and thereby act as a mem-
brane signaling platforms to launch and catalyze the transmission
of apoptotic signals (Mollinedo and Gajate, 2010a,b). The pro-
tein composition of these CASMERs includes death receptors and
downstream signaling molecules (Gajate and Mollinedo, 2005;
Gajate et al., 2009b; Mollinedo and Gajate, 2010a,b). On these
grounds, lipid rafts play a major role in the generation of apop-
totic signals in mammalian cells. In contrast to mammalian cells,
yeasts lack death receptors and most of the typical apoptotic
molecules, so the involvement of rafts in the cell death process
might be less obvious in yeast. However, lipid rafts seem to be
critical structures and scaffolds for the proper function of pro-
teins whose activities are required for the normal function of a
yeast cell, including yeast survival and growth (Figure 2), such
as proteins involved in ion homeostasis and nutrient transport
(Table 1). In this regard, it might be envisaged that redistribution
and displacement of raft-located proteins to non-raft domains
might lead to a failure in yeast functioning and eventually to
cell death.
In mammalian cells, lipid rafts usually house proteins involved
in survival signaling and growth, and thereby their presence is
expected to play a role in the proliferation and survival of cancer
cells. However, as indicated above, recent evidence in the last few
years has also shown the presence of rafts enriched in death recep-
tors and apoptotic molecules, leading to the emerging concept
of the proapoptotic CASMER. Thus, at least two major differ-
ent raft domains leading to survival and cell death can apparently
be formed in mammalian cells. However, because yeast cells lack
death receptors and the classical mammalian-like caspases, yeast
rafts are supposed to be involved only in rather positive outcomes
that keep the yeast cell alive. According to this notion, it might
be envisaged that lipid raft disruption could facilitate and prompt
yeast cell death.
The cationic amphipathic and antiarrhythmic drug amio-
darone interacts with lipid membranes to exert their biological
effect. In S. cerevisiae, toxic levels of amiodarone trigger a tran-
sient membrane hyperpolarization, likely through its ability to
intercalate into the lipid bilayer (Herbette et al., 1988) altering
lipid ﬂuidity (Rosa et al., 2000), which is followed by depolariza-
tion, coincident with inﬂux of Ca2+ and H+ that can overwhelm
cellular homeostasis and lead to cell death (Maresova et al., 2009).
Amiodarone has been shown to have potent fungicidal activity
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FIGURE 2 | Putative involvement of lipid rafts in different yeast functions.
against not only S. cerevisiae, but also for species of Crypto-
coccus, Candida, Fusarium, and Aspergillus (Courchesne, 2002).
Using a genome-wide screen in a S. cerevisiae single-gene deletion
library, 36 yeast strains with amiodarone hypersensitivity were
identiﬁed, including mutants in transporters (PMR1, PDR5, vac-
uolar H+-ATPase), ergosterol biosynthesis (ERG3, ERG6, ERG24),
intracellular trafﬁcking (VPS45, RCY1), and signaling (YPK1,
PTC1; Gupta et al., 2003). The fact that azole resistant mutants
in the ergosterol biosynthesis pathway of S. cerevisiae (erg3,
erg6, and erg24) exhibited hypersensitivity to amiodarone,
suggests that the drug may be particularly effective for treat-
ment against azole-resistant fungal strains (Gupta et al., 2003),
which might be defective in raft-mediated processes. In addition,
low doses of amiodarone and an azole (miconazole, ﬂucona-
zole) are strongly synergistic and show potent fungicidal effects
in combination (Gupta et al., 2003). These data suggest that
lipid raft disruption might favor amiodarone cytotoxic action
against yeast.
The initial hyperpolarization seems to be critical for the amio-
darone cytotoxic effect. Glucose increases membrane potential by
increasing H+ pumping activity of the plasma membrane ATPase
Pma1p (Serrano, 1983). Downregulation of the H+ pump activ-
ity of the yeast plasma membrane upon glucose removal (Serrano,
1983) was accompanied by an attenuation of amiodarone-induced
Ca2+ burst, thus protecting against drug toxicity (Muend and
Rao, 2008). Amiodarone-induced hyperpolarization was lower in
the mutant strain pma1-105 that has 65% reduction in activity
(Perlin et al., 1989). Furthermore, a decrease in membrane poten-
tial by glucose removal, addition of salts or in tok1, ena1-4,
or nha1mutants, involved in ion homeostasis, protected against
amiodarone toxicity, suggesting that initial hyperpolarization was
important in themechanismof antifungal activity (Maresova et al.,
2009). Thus, there is a link between membrane hyperpolarization
and amiodarone toxicity. Because ion homeostasis and membrane
potential is mainly regulated by raft-located proteins, these data
also involve thesemembrane domains in the cytotoxicity of certain
fungal drugs.
Interestingly, a recent work by Tulha et al. (2012) has shown
that deletion of GUP1 in S. cerevisiae leads to hypersensitivity to
acetic acid treatment, high levels of reactive oxygen species (ROS)
and reduced lifespan, leading to yeast cell death, likely through
necrosis rather than apoptosis. Gup1p is a membrane-bound O-
acyltransferase involved in remodeling GPI anchors (Bosson et al.,
2006), playing an important role in the assembly/integrity of lipid
rafts (Ferreira and Lucas, 2008). Because gup1mutant is affected
in lipid raft integrity/assembly, lipid metabolism, and GPI-anchor
remodeling, the above data (Tulha et al., 2012) suggest a role of
lipid rafts in yeast cell death process, and in the type of cell
death process that ensues reorganization of plasma membrane
domains.
Cytotoxicity of the antitumor ether phospholipid edelfos-
ine against S. cerevisiae has been shown to be enhanced in
yeast mutants defective for LCB1, an essential serine palmitoyl-
transferase that catalyzes the ﬁrst step in sphingolipid synthesis,
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and ERG3, a sterol C-5 desaturase involved in the ﬁnal steps
of ergosterol synthesis (Zaremberg et al., 2005). On the other
hand, S. cerevisiae mutants affected in sphingolipid and ergosterol
biosynthesis, namely ipt1, sur1, skn1, and erg3 deletion
mutants, are resistant to the azole antimycoticsmiconazole,mainly
due to the role of lipid rafts in mediating intracellular accumu-
lation of miconazole in yeast cells (Francois et al., 2009). Taken
together these data suggest a major role of lipid rafts in the
cytotoxicity of drugs in yeast.
In this regard, a number of data support that absence of
ergosterol, which is one of the major constituents of membrane
rafts, has a direct effect on drug susceptibility and morpho-
genesis of C. albicans. Low doses of amiodarone have been
reported to be synergistic with ﬂuconazole in ﬂuconazole-resistant
C. albicans (Gamarra et al., 2010). Ergosterol deﬁciency in erg1
mutants led to defects in growth and increased susceptibilities to
drugs, including ﬂuconazole, ketoconazole, cycloheximide, nys-
tatin, amphotericin B, and terbinaﬁne in C. albicans (Pasrija et al.,
2005a,b). Reduced drug efﬂux activity of the erg1 mutant was
associated with poor surface localization of Cdr1p, suggesting that
enhanced passive diffusion and reduced efﬂux mediated by the
ABC transporter Cdr1p increases drug susceptibility. Addition-
ally, conditional erg1mutant strains were unable to form hyphae
in various media in C. albicans (Pasrija et al., 2005a,b). Likewise,
the loss of (M(IP)2C) in the C. albicans ipt1 mutant, a sph-
ingolipid biosynthetic gene, resulted in increased sensitivity to
drugs like 4-nitroquinoline oxide, terbinaﬁne, o-phenanthroline,
ﬂuconazole, itraconazole, and ketoconazole. The increase in drug
susceptibilities of ipt1mutant cells was linked to an altered sph-
ingolipid composition, which appeared to be due to the impaired
functionality of Cdr1p, a major drug efﬂux pump of C. albi-
cans that belongs to the ABC superfamily (Prasad et al., 2005).
Taken together, the above data indicate that an altered compo-
sition of sphingolipid or ergosterol, the major constituents of
membrane rafts, affects drug susceptibility and morphogenesis in
C. albicans.
ACTIN CYTOSKELETON, RAFTS, AND STRESS RESPONSE
Wild-type S. cerevisiae cells depolarize actin following salt stress
and repolarize after a period of adaptation (Chowdhury et al.,
1992; Balguerie et al., 2002). Two proteins are mainly involved
in this process, namely Wsc1p for actin depolarization and
the amphiphysin-like protein Rvs161p for actin repolarization
(Balguerie et al., 2002). Thus, rvs161 mutant was able to depo-
larize actin in response to NaCl stress, but was unable to repolarize
afterward, whereas wsc1 mutants was impaired in depolarizing
actin (Balguerie et al., 2002). RVS161/END6 gene, the budding
yeast homolog of amphiphysin (Sivadon et al., 1995; Youn et al.,
2010), is associated, in part, with lipid rafts (Balguerie et al., 2002),
and co-localizes with actin patches (Balguerie et al., 1999), thus
suggesting a link between rafts and actin cytoskeleton in S. cere-
visiae. Rvs161p is suggested to locate in rafts through a putative
association with a raft-bound protein, as Rvs161p has no GPI sig-
nal anchor or transmembrane domain, and therefore it cannot be
directly integrated in rafts. The SLG1/WSC1 gene product has also
been reported to be partially present inDRMs (Lodder et al., 1999).
Clustering of Slg1p/Wsc1p is enhanced under stress conditions,
either heat or hypo-osmotic shock, as assessed by single-molecule
atomic forcemicroscopy, suggesting its relevance in stress response
(Heinisch et al., 2010). Thus, lipid rafts could function as platforms
for actin depolarization and actin repolarization in response to
stress in S. cerevisiae.
In yeast, nutrient starvation leads to entry into stationary phase.
RVS161 (RVS for Reduced Viability upon Starvation) was identi-
ﬁed as a critical gene to respond properly to carbon, nitrogen, and
sulfur starvation conditions in S. cerevisiae, and it has been impli-
cated in the control of cellular viability. Thus, rvs161mutant cells
die during the stationary phase and show sensitivity to high salt
concentrations (Crouzet et al., 1991). Rvs161 displays a pheno-
type similar to that shown for the actinmutants: actin cytoskeleton
disorganization, random budding of the diploids, loss of polarity,
and sensitivity to salt. In addition, rvs161, together with muta-
tions in the actin gene, ACT1, leads to synthetic lethality (Breton
andAigle, 1998), thus suggesting that actin and Rvs161p are linked
in a common functional pathway that is critical for yeast viability
under stress conditions. These data might suggest a role of lipid
rafts as platforms for the interaction of proteins that are required
for yeast survival.
Rvs167p, another amphiphysin-like protein that interacts with
Rvs161p to regulate actin cytoskeleton, endocytosis, and viabil-
ity following starvation and osmotic stress, has been reported
to localize to Rvs161p-containing lipid rafts (Germann et al.,
2005). Several protein networks involved in diverse cellular func-
tions, including endocytosis/vesicle trafﬁc, converge on Rvs161p-
Rvs167p complex (Bon et al., 2000), and therebyRvs167p-Rvs161p
complex might act as a docking platform for proteins involved
in the regulation of different biological processes requiring actin
cytoskeleton (Germann et al., 2005). In addition, the rvs mutants
accumulate late secretory vesicles at sites of membrane and cellwall
construction, and are synthetic-lethal with the slt2/mpk1muta-
tion, which affects the MAP kinase cascade controlled by Pkc1p
and is required for cell integrity (Breton et al., 2001). These data
support the idea that the RVS proteins, and thereby lipid rafts, are
involved in the late targeting of vesicles whose cargoes are required
for cell wall construction.
Actin-linking proteins ezrin, moesin, RhoA, and RhoGDI were
shown to be recruited into clusters of Fas/CD95-enriched rafts
in human leukemic cells upon treatment with the anticancer drug
aplidin (Gajate andMollinedo, 2005). Disruption of lipid rafts and
interference with actin cytoskeleton prevented Fas/CD95 cluster-
ing and apoptosis, suggesting a major role of actin cytoskeleton
in the formation of Fas/CD95 clusters and in the aggregation of
proteins in lipid raft clusters in human cancer cells, thus regulat-
ing raft-associated signaling events (Gajate and Mollinedo, 2005).
There is increasingof evidence of structuringof rafts by the cortical
actin cytoskeleton, including evidence that the actin cytoskeleton
associateswith rafts, and thatmanyof the structural and functional
properties of rafts require an intact actin cytoskeleton (Chichili
and Rodgers, 2009; Ayling et al., 2012).
In yeast, stabilization of actin by addition of jasplakinolide,
by point mutations in the ACT1 gene, or by deletion of certain
genes that regulate F-actin, leads to cell death. Yeast mutant lack-
ing the gene END3 shows stabilized actin and elevated levels of
ROS, this phenotype being dependent on downstream elements of
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the Ras/cAMP pathway (Gourlay and Ayscough, 2006). Following
yeast treatmentwithmethyl-β-cyclodextrin, which depletes sterols
from plasma membrane and disrupts lipid rafts, and manumycin
A, that blocks prenylation, Ras2 membrane association and the
level of ROS were reduced, and cell death progression was inhib-
ited (Du and Ayscough, 2009). These data suggest that lipid rafts
in yeast could be somehow related to providing platforms for
the generation of stable complexes that could launch pro-cell
death signals. This could open the possibility that lipid rafts in
yeast could provide appropriate membrane domains for pro-cell
death signaling molecules, as it has been recently described in
mammalian cells, and not only for survival and growth signal-
ing. However, this pro-cell death view of rafts in yeast remains
to be elucidated, and further studies as well as the molecu-
lar characterization of the putative processes involved will be
required.
LIPID RAFTS AND EISOSOMES
Studies on the budding yeast S. cerevisiae have revealed that fun-
gal plasma membranes are organized into different subdomains.
Pma1p (plasma membrane H+-ATPase) and Can1p (H+-arginine
symporter) have been located in lipid raft membrane domains,
but, as stated above, these proteins occupy two different non-
overlapping membrane microdomains (Malinska et al., 2003).
Thus, at least two different types of rafts can be distinguished in
the yeast plasma membrane. Similarly to what was observed with
Can1p, a family of integral membrane proteins, including Sur7p,
Ynl194p, andYdl222p,were visualized in cortical patches in S. cere-
visiae (Young et al., 2002). Current evidence suggests the existence
of at least two subcellular compartments in the yeast plasma mem-
brane, namely a raft-based membrane compartment represented
by a network-like structure housing Pma1p, and another raft-
based membrane compartment that houses a number of proton
symporters (Can1p, Fur4p, Tat2p). These two raft domains, also
namedas themembrane compartment occupiedbyPma1p (MCP)
andmembrane compartment occupiedbyCan1p (MCC;Malinska
et al., 2004; Grossmann et al., 2007), apparently require different
lipids to keep their respective protein compositions (Figure 3). The
proper sorting of Pma1p has been reported to be more dependent
on sphingolipids, ceramide, and the C26 acyl chain that forms part
of the ceramide (Lee et al., 2002; Gaigg et al., 2005, 2006). However,
sterols are required for the correct targeting of Tat2p (Umebayashi
and Nakano, 2003). Thus, these data suggest the putative existence
of raft domains more enriched in either sphingolipids or sterol-
rich in the yeast membrane, each one containing a speciﬁc set
of proteins, and this compartmentalization or lateral segregation
seems to be dependent on the membrane potential (Grossmann
et al., 2007). Plasma membrane depolarization caused reversible
dispersion of the H+ symporters previously present in 300-nm
patches (Grossmann et al., 2007). In addition, yeast plasma mem-
brane seems to contain an additional subdomainnamed eisosomes
(from the Greek “eis,” meaning into or portal, and “soma,” mean-
ing body), which are immobile protein complexes, composed
mainly of the cytoplasmic proteins Pil1p and Lsp1p at the plasma
membrane that mark static sites of endocytosis (Walther et al.,
2006). Pil1p and Lsp1p form punctuate clusters (eisosomes) on
the cytoplasmic surface of the plasma membrane at MCC sites
(Walther et al., 2006) and associate with the plasma membrane
via their BAR domains (named for the Bin/Amphiphysin/Rvs pro-
teins), that bindmembranes and promote curvature (Zimmerberg
and McLaughlin, 2004). Eisosomes form at the sites of invagi-
nations in the plasma membrane, being ﬂanked by Can1p-rich
MCC domains at the upper edges of the furrows, whereas Pil1p
is located at the bottom of the furrow (Stradalova et al., 2009;
Douglas et al., 2011) and Sur7p, a protein involved in endocyto-
sis, seems to be at the boundary between MCC and eisosomes
(Figure 3). Microscopic and genetic analyses link these stable,
ultrastructural assemblies, named eisosomes, to the endocytosis of
both lipid and protein cargoes in cells, and aremainly composed of
BAR domain proteins (Douglas et al., 2011; Olivera-Couto et al.,
2011). Eisosomes have been suggested to function as organizing
sites for endocytosis (Toret and Drubin, 2006). Thus, degradation
of the arginine permease Can1p induced by excess of its substrate
required ﬁrst Can1p release from MCC patches, and only then it
was endocytosed (Grossmann et al., 2008), thus suggesting that
the protein is to a large extent unavailable for endocytosis and
subsequent degradation as long as it stays in the protective area of
MCC (Malinsky et al., 2010). In this regard, rapidly moving endo-
cytic marker proteins avoid raft domains, and consequently the
raft domain-accumulated proton symporters show a reduced state
of substrate-induced endocytosis and turnover (Malinsky et al.,
2010). Genetic analysis of the MCC/eisosome components indi-
cates that these domains broadly affect overall plasma membrane
organization (Douglas et al., 2011). The analysis of the major con-
stituents of eisosomes, i.e., BAR proteins, is of major importance
also inmammalian cells. BAR family proteins contribute to a range
FIGURE 3 | Schematic view of yeast MCP, MCC, and eisosome membrane subdomains.
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of cellular functions characterized by membrane and cytoskele-
tal remodeling, inducing membrane curvature and recruitment of
effector proteins, with important consequences in several human
disorders, including cancer cell invasiveness, as well as immune
and neurologic disorders (Chen et al., 2012).
PERSPECTIVES
Recognition of the presence of distinct domains at the cell mem-
brane has been one of the most signiﬁcant scientiﬁc achievements
in the last decades. Lipid raft membrane domains are gaining
momentum in current biology, and they seem to regulate a wide
number of critical processes. Lipid rafts are variable in size and
composition, and can change in a highly dynamic way both by
recruiting and expelling components as well as by coalescing
smaller raft units, forming large clusters. The presence of these
membrane domains in all eukaryotic cells opens newways to study
the physiological role of rafts in distinct biological systems. The
existence of lipid rafts in yeast has provided an excellent way to
study the role of these membrane domains in different biolog-
ical processes, due to the remarkable yeast genetic tractability.
Thus, changes in ergosterol and sphingolipid composition, the
major raft constituents in yeast, by disrupting key metabolic genes
lead to improper surface localization of major proteins involved
in keeping yeast viable against some external aggression, includ-
ing proteins involved in ion homeostasis, drug efﬂux, and stress
response. Yeast lipid rafts house proteins that are critical for the
regulation of membrane potential, intracellular pH, and nutrient
transport. In fact, the plasma membrane potential is mainly con-
sidered as the driving force for ion and nutrient translocation in
yeast, and the correct location of the proteins involved in these
processes in lipid rafts is crucial for the proper functioning of the
yeast. Lipid rafts could also behave as scaffolds where proteins
dock and concentrate to either launch signals to be transmitted
to other parts of the cell or to build new structures required for
cell integrity or cell division. Thus, yeast cells constitute an excel-
lent biological system to analyze the role of lipid rafts in both
survival and cell death responses, in spite of lacking most apop-
totic molecules present in mammalian cells. Key proteins for yeast
survival and proper yeast functioning are localized in lipid rafts,
and their displacement from raft domains leads to cell death. In
addition, drugs interacting with sterols affect lipid raft compo-
sition and membrane integrity and are detrimental to yeast. In
addition, yeast plasma membrane contains at least three distinct
subdomains that appear to have specialized functions, and they
could interact each other. Understanding the dynamic structure
of lipid rafts in yeast, as well as their mobility, composition, and
biological role, will be of an inestimable value in getting a bet-
ter insight into the role of these membrane domains in survival
and cell death signaling. This insight will recognize the impor-
tance of membrane lipids in cellular function, highlighting lipid
rafts as a new and promising therapeutic target (Mollinedo and
Gajate, 2006), and could be useful for the search of novel anti-
fungal agents and, following extrapolation to mammalian cells, to
hopefully set up the underlying bases for the treatment of human
diseases. Membrane compartmentalization in lipid rafts plays a
key role in signaling process in mammalian cells, and this aspect
might also be true in yeast as a plethora of processes seem to involve
proteins located in these yeast membrane domains. Thus, a better
knowledge of the yeast lipid raft composition and function might
help us to gain insight in the regulation of critical processes regard-
ing cell fate, which might be extrapolated to other organisms and
could be valuable to conceive new approaches in the treatment of
human diseases where cell death and survival are critical, such as
cancer and neurodegenerative diseases.
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